News

Allergy Therapeutics Selects AGC Biologics to Manufacture Peanut Allergy Vaccine Candidate

News

AGC Biologics is producing vaccine materials for early-stage product trials at its Heidelberg facilities

Follow Us
Join us on LinkedIn Follow us on Twitter